MIRA报告新药Ketamir-2成功治疗了大鼠的糖尿病神经疼痛,没有副作用。 MIRA reports new drug Ketamir-2 successfully treats diabetic nerve pain in rats without side effects.

MIRA制药公司报告说,其药物Ketamir-2在治疗大鼠糖尿病神经病方面取得了成功的成果,在没有传统氯胺酮副作用的情况下显著减轻了疼痛。 MIRA Pharmaceuticals has reported successful results for its drug Ketamir-2 in treating diabetic neuropathy in rats, showing significant pain reduction without the side effects of traditional ketamine. 在临床学前研究中,药物的效绩超过了目前的药物,并且正在作为一种非类阿片替代药物进行开发。 The drug outperformed current medications in preclinical studies and is being developed as a non-opioid alternative. MIRA计划到年底进行第二阶段人类试验,以大量糖尿病神经病患者为对象,提供更安全、更有效的治疗办法。 MIRA plans Phase II human trials by year-end, targeting the large diabetic neuropathy patient population with a safer, more effective treatment option.